Nautilus Biotechnology Inc. (NAUT) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Nautilus Biotechnology In... (NAUT)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.91

0.05 (2.69%)

At close: Jan 15, 2025, 12:23 PM

undefined% (undefined)

Bid	1.9
Market Cap	239.83M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.56
PE Ratio (ttm)	-3.41
Forward PE	n/a
Analyst	Sell

Ask	1.92
Volume	48,299
Avg. Volume (20D)	138,880
Open	1.90
Previous Close	1.86
Day's Range	1.90 - 2.00
52-Week Range	1.61 - 3.12
Beta	undefined

About NAUT

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington....

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Aug 7, 2020

Employees 161

Stock Exchange NASDAQ

Ticker Symbol NAUT

Website https://www.nautilus.bio

Analyst Forecast

According to 3 analyst ratings, the average rating for NAUT stock is "Sell." The 12-month stock price forecast is $3, which is an increase of 57.07% from the latest price.

Buy 33.33%

Hold 33.33%

Sell 33.33%

Stock Forecasts

Why Price Moved

6 months ago · Source

+2.7%

Nautilus Biotechnology shares are trading higher a... Unlock content with Pro Subscription

8 months ago · Source

-1.17%

Nautilus Biotechnology shares are trading higher after the company reported better-than-expected Q1 EPS results.

News

2 months ago · seekingalpha.com

Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2024 Earnings Conference Call October 29, 2024 8:30 AM ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder and Chief Executiv...